到 2027 年北美心房颤动市场 - 按治疗类型（非药物、药物）进行区域分析和预测；最终用户（医院、门诊手术中心、心导管实验室）和国家/地区
No. of Pages: 166 | Report Code: TIPRE00009243 | Category: Life Sciences
No. of Pages: 166 | Report Code: TIPRE00009243 | Category: Life Sciences
心房颤动是其中之一最常见的心脏病，会导致心率不规则且通常异常快，从而可能导致中风。全球有很多人不知道与心房颤动相关的症状，因此仍未得到治疗。例如，曼彻斯特健康创新中心于 2018 年 11 月提高了人们对心房颤动和其他创新技术的认识，以提高该疾病的检测率，作为全球房颤意识周的一部分。
除了协会和组织等机构外，市场上的公司也在提高对房颤的认识方面发挥了重要作用。例如，Biosense Webster（强生公司的一个部门）。作为 11 月 18 日至 24 日全球房颤意识周的一部分，约翰逊发起了两项重大举措。作为名为 Get Smart About AFIB (GSAAF) 行动的一部分，该公司与心律失常联盟建立了战略合作伙伴关系，以增加医疗界和公众对 AF 的了解。由于意识有助于改善心房颤动治疗所需的医疗护理，预计该市场在预测期内将出现可观的增长
美国预计将主导该市场由于老年人口不断增长和医疗保健创新数量不断增加，北美地区的市场不断扩大。因此，考虑到上述因素，预计在预测期内，美国心房颤动市场将大幅增长。
< p>
Strategic insights for North America Atrial Fibrillation involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 2,285.69 Million |
| Market Size by 2027 | US$ 6,284.87 Million |
| Global CAGR (2020 - 2027) | 13.7% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 治疗类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Atrial Fibrillation refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - North America Atrial Fibrillation Market
The North America Atrial Fibrillation Market is valued at US$ 2,285.69 Million in 2019, it is projected to reach US$ 6,284.87 Million by 2027.
As per our report North America Atrial Fibrillation Market, the market size is valued at US$ 2,285.69 Million in 2019, projecting it to reach US$ 6,284.87 Million by 2027. This translates to a CAGR of approximately 13.7% during the forecast period.
The North America Atrial Fibrillation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Atrial Fibrillation Market report:
The North America Atrial Fibrillation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Atrial Fibrillation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Atrial Fibrillation Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Atrial Fibrillation Market
